FLUBLOK TRIVALENT NORTHERN HEMISPHERE 45 ug/.5mL
INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN · INJECTION · Sanofi Pasteur Inc.
FLUBLOK TRIVALENT NORTHERN HEMISPHERE is a injection containing influenza a virus a/west virginia/30/2022 (h1n1) recombinant hemagglutinin antigen, influenza a virus a/district of columbia/27/2023 (h3n2) recombinant hemagglutinin antigen, and influenza b virus b/austria/1359417/2021 recombinant hemagglutinin antigen at 45 ug/.5mL, taken intramuscular. Manufactured by Sanofi Pasteur Inc..
Key Facts
- Brand Name
- FLUBLOK TRIVALENT NORTHERN HEMISPHERE
- Generic Name
- INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN
- NDC Code (Product)
49281-725- Manufacturer
- Sanofi Pasteur Inc.
- Strength
- 45 ug/.5mL
- Dosage Form
- INJECTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125285
- Marketing Start
- 07/01/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is FLUBLOK TRIVALENT NORTHERN HEMISPHERE used for?
FLUBLOK TRIVALENT NORTHERN HEMISPHERE contains INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN. It is a injection taken intramuscular. Consult your doctor for specific uses.
Is FLUBLOK TRIVALENT NORTHERN HEMISPHERE a controlled substance?
FLUBLOK TRIVALENT NORTHERN HEMISPHERE is not classified as a controlled substance by the DEA.
What is the generic name for FLUBLOK TRIVALENT NORTHERN HEMISPHERE?
The generic name for FLUBLOK TRIVALENT NORTHERN HEMISPHERE is INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN. There are no other listed brand versions of INFLUENZA A VIRUS A/WEST VIRGINIA/30/2022 (H1N1) RECOMBINANT HEMAGGLUTININ ANTIGEN, INFLUENZA A VIRUS A/District of Columbia/27/2023 (H3N2) RECOMBINANT HEMAGGLUTININ ANTIGEN, and INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 RECOMBINANT HEMAGGLUTININ ANTIGEN.
What is the NDC code for FLUBLOK TRIVALENT NORTHERN HEMISPHERE 45 ug/.5mL?
The NDC (National Drug Code) for FLUBLOK TRIVALENT NORTHERN HEMISPHERE 45 ug/.5mL is 49281-725, listed by Sanofi Pasteur Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)